药物参与变化过量死亡峰值:马萨诸塞州县级分析
Daniel Otero-Leon1,2, Hannah Lee1, Huiru Dong1
1Harvard Medical School, Boston, Massachusetts, USA.
BMJ public health
|July 15, 2025
概括
药物过量峰值显示在马萨诸塞州各县的各种物质参与. 在几个县的高峰期,可卡因更为常见,这凸显了需要本地公共卫生战略来打击过量死亡的必要性.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 药物使用研究研究 药物使用研究
背景情况:
- 药物过量死亡发生在不可预测的激增,需要了解这些关键时期涉及的物质.
- 识别与过量剂量峰值相关的特定药物对于有效的公共卫生干预至关重要.
- 这项研究侧重于马萨诸塞州,以分析州和县级过量死亡事件中的物质参与.
研究的目的:
- 调查涉及马萨诸塞州过量使用高峰的特定物质.
- 为了比较可卡因,精神兴奋剂,芬太尼,海洛因和处方阿片类药物的使用率,在过量剂量高峰期间与典型日相比.
- 在州和县两级分析这些模式.
主要方法:
- 一个尖端检测算法从9915起死亡事件 (2020-2023) 中识别出每日过量死亡尖端 (超过30天移动平均线的2个SD).
- 一般线性混合模型比较了关键物质 (可卡因,精神兴奋剂,芬太尼,海洛因,处方阿片类药物) 在高峰和典型日的存在.
- 分析包括马萨诸塞州14个县中的8个县,每日过量死亡人数最高.
主要成果:
- 在州一级,在峰值日和典型日之间没有发现显著的物质差异.
- 在多个县的高峰期,可卡因更为普遍.
- 芬太尼在两个县的典型日期更常见,而精神兴奋剂因县而异;海洛因和处方阿片类药物在特定县的差异有限.
结论:
- 过量服用死亡峰值在马萨诸塞州各县显示出与物质相关的显著异质性.
- 这些发现强调了针对性,本地化公共卫生战略的必要性.
- 了解特定县的模式可以优化资源分配和改善干预措施,以减轻未来过量事件的影响.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
659
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
659
Analysis of Population Pharmacokinetic Data
390
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
390
Agonism and Antagonism: Quantification
579
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
579
Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K
Drug Concentration Versus Time Correlation
1.2K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.2K
Pharmacovigilance
996
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996


